These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2132174)

  • 1. 5-Hydroxytryptamine-receptor subtypes.
    Brodde OE
    Clin Physiol Biochem; 1990; 8 Suppl 3():19-27. PubMed ID: 2132174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of serotonin agonists and antagonists.
    Saxena PR; Villalón CM
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S17-34. PubMed ID: 1702484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and classification of 5-HT1 receptor subtypes.
    Göthert M; Schlicker E
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S1-7. PubMed ID: 1702482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor.
    Conner DA; Mansour TE
    Mol Pharmacol; 1990 May; 37(5):742-51. PubMed ID: 2338946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of serotonin receptors.
    Göthert M; Schlicker E
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S3-7. PubMed ID: 2446065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor.
    Craig DA; Clarke DE
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1378-86. PubMed ID: 2319473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
    Hoyer D; Clarke DE; Fozard JR; Hartig PR; Martin GR; Mylecharane EJ; Saxena PR; Humphrey PP
    Pharmacol Rev; 1994 Jun; 46(2):157-203. PubMed ID: 7938165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
    de Ridder WJ; Schuurkes JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-hydroxytryptamine: considerations about discovery, receptor classification and relevance to medical research.
    Villalón CM; Terrón JA; Ramírez-San Juan E; Saxena PR
    Arch Med Res; 1995; 26(4):331-44. PubMed ID: 8555727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses?
    Montgomery SA; Fineberg N
    Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
    Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A
    Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates.
    Pandey SC; Davis JM; Pandey GN
    J Psychiatry Neurosci; 1995 May; 20(3):215-25. PubMed ID: 7786883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.